Up Next
New Treatment For Pancreatic Cancer Lengthens Survival Time For Patients
August 31, 2026
A breakthrough in treating one of the deadliest diseases. Pancreatic cancer reportedly kills 50,000 Americans a year. After a promising clinical trial, the FDA quickly approved Daraxonrasib, which nearly doubled a patient's survival time compared to chemotherapy. Researchers say it gave patients about 13 months, but not without side effects. Inside Edition Digital’s Mara Montalbano has more.





































































































































































































